Congratulations Paul, I think you guys have picked a really important niche in public healthcare and I wish you all the best.
For those who're unacquainted with the problems of public healthcare in developing countries, one of the biggest challenges when treating long-term illnesses like tuberculosis and HIV-AIDS is that it's difficult to ensure that patients comply with the demanding medicine regimen that often has to continue for months or years. It's especially tricky in rural areas where patients return home and can not easily be monitored by healthcare workers.
If patients don't comply not only are their chances of successful treatment dramatically reduced but they increase the risk of drug-resistant disease strains like XDR-TB of emerging.
So something like Mediminder, if widely adopted, has the potential to save many lives and in one small but important way help developing countries get a handle on some of their most devastating diseases.
For those who're unacquainted with the problems of public healthcare in developing countries, one of the biggest challenges when treating long-term illnesses like tuberculosis and HIV-AIDS is that it's difficult to ensure that patients comply with the demanding medicine regimen that often has to continue for months or years. It's especially tricky in rural areas where patients return home and can not easily be monitored by healthcare workers.
If patients don't comply not only are their chances of successful treatment dramatically reduced but they increase the risk of drug-resistant disease strains like XDR-TB of emerging.
So something like Mediminder, if widely adopted, has the potential to save many lives and in one small but important way help developing countries get a handle on some of their most devastating diseases.